Nanexa signs agreement with US pharmaceutical company for evaluation of PharmaShell®
Uppsala 19th November 2019
Nanexa signs agreement with US pharmaceutical company for evaluation of PharmaShell®
Nanexa has today signed a Material Transfer and Feasibility study Agreement with an unnamed global pharmaceutical company located in the US and a subsidiary of a global Japanese pharmaceutical company.
Nanexa receives “Notice of Allowance” for another patent application in the US
Pressrelease
Uppsala 2nd October 2019
Nanexa receives “Notice of Allowance” for another patent application in the US.
Nanexa has received a so-called “Notice of Allowance”
